Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

SINOPHARM (1099.HK)

18.300
+0.140
+(0.77%)
At close: 4:08:23 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
584,507,930
584,507,930
596,569,565
552,147,550
521,051,235
Cost of Revenue
540,252,540
540,252,540
548,057,887
504,713,490
477,000,627
Gross Profit
44,255,390
44,255,390
48,511,678
47,434,060
44,050,608
Operating Expense
26,484,908
26,484,908
26,234,719
24,893,424
22,609,333
Operating Income
17,770,482
17,770,482
22,276,959
22,540,636
21,441,275
Net Non Operating Interest Income Expense
-2,328,242
-2,328,242
-2,430,374
-3,189,992
-3,402,869
Pretax Income
14,000,899
14,000,899
19,512,137
18,563,819
17,003,162
Tax Provision
3,577,305
3,577,305
4,502,309
4,218,377
3,938,389
Net Income Common Stockholders
7,049,683
7,049,683
9,053,760
8,525,655
7,758,646
Diluted NI Available to Com Stockholders
7,049,683
7,049,683
9,053,760
8,525,655
7,758,646
Basic EPS
2.26
2.26
2.90
2.73
2.49
Diluted EPS
2.26
2.26
2.90
2.73
2.49
Basic Average Shares
3,120,532
3,120,532
3,120,532
3,120,656
3,111,169
Diluted Average Shares
3,120,532
3,120,532
3,120,532
3,120,656
3,111,169
Total Operating Income as Reported
16,188,403
16,188,403
20,209,195
20,604,466
19,711,976
Total Expenses
566,737,448
566,737,448
574,292,606
529,606,914
499,609,960
Net Income from Continuing & Discontinued Operation
7,049,683
7,049,683
9,053,760
8,525,655
7,758,646
Normalized Income
9,039,792.549
9,039,792.549
10,230,009.699
10,016,537.669
9,464,882.810
Interest Income
616,970
616,970
743,366
542,767
558,562
Interest Expense
2,734,038
2,734,038
2,956,587
3,520,326
3,756,835
Net Interest Income
-2,328,242
-2,328,242
-2,430,374
-3,189,992
-3,402,869
EBIT
16,734,937
16,734,937
22,468,724
22,084,145
20,759,997
EBITDA
21,468,629
21,468,629
26,898,972
26,249,164
24,682,055
Reconciled Cost of Revenue
540,252,540
540,252,540
548,057,887
504,713,490
477,000,627
Reconciled Depreciation
4,733,692
4,733,692
4,430,248
4,165,019
3,922,058
Net Income from Continuing Operation Net Minority Interest
7,049,683
7,049,683
9,053,760
8,525,655
7,758,646
Total Unusual Items Excluding Goodwill
-2,673,082
-2,673,082
-1,528,987
-1,929,196
-2,220,506
Total Unusual Items
-2,673,082
-2,673,082
-1,528,987
-1,929,196
-2,220,506
Normalized EBITDA
24,141,711
24,141,711
28,427,959
28,178,360
26,902,561
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-682,972.451
-682,972.451
-352,737.301
-438,313.331
-514,269.190
12/31/2021 - 9/23/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0401.HK WANJIA GROUP
0.071
0.00%
 
EPMT.JK PT Enseval Putera Megatrading Tbk.
2,380.00
+1.28%
 
AMFPF Amplifon S.p.A.
21.00
+10.53%
 
2607.HK Shanghai Pharmaceuticals Holding Co., Ltd
10.980
+2.23%
 
ITNS Itonis, Inc.
0.0004
0.00%
 
AMP.VI Amplifon S.p.A.
19.18
+2.59%
 
ARJO-B.ST Arjo AB (publ)
30.20
-1.50%
 
GALE.SW Galenica AG
87.70
-0.57%
 
QIPT.TO Quipt Home Medical Corp.
2.9450
+0.86%
 
SIG.AX Sigma Healthcare Limited
2.9600
+0.68%